• 1
    Tuberculosis, NIAID Fact Sheet. (2002).
  • 2
    World Health Organization – Leprosy. Global leprosy situation in 2003.
  • 3
    Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346: 133945 .
  • 4
    Mustafa AS. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2001;2: 15773.
  • 5
    Mustafa AS. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 2002;39: 1139.
  • 6
    Mustafa AS, Al-Attiyah R. Tuberculosis: Beyond BCG vaccines. J Postgrad Med 2003;49: 13440.
  • 7
    Mustafa AS. HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Hum Immunol 2000;61: 16671.
  • 8
    Mustafa AS, Oftung F, Deggerdal A, Gill HK, Young RA, Godal T. Gene isolation with human T lymphocyte probes. Isolation of a gene that expresses an epitope recognized by T cell specific for Mycobacterium bovis BCG and pathogenic mycobacteria. J Immunol 1988;141: 272933.
  • 9
    Oftung F, Wiker H, Deggerdal A, Musatafa AS. A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins. Scand J Immunol 1997;46: 44551.
  • 10
    Mustafa AS, Deggeredal A, Lundin KA, Meleon RM, Shinninck TM, Oftung F. An HLA-DRw53-restricted T cell epitope from a novel Mycobacterium leprae protein antigen important to the human memory T cell repertoire against M. leprae. Infect Immun 1994;62: 5595602.
  • 11
    Mustafa AS, Oftung F. Long-lasting T cell reactivity Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae. Vaccine 1993;11: 110812.
  • 12
    Singh H, Raghava GPS. ProPred: Prediction of HLA-DR binding sites. Bioinformatics 2001;17: 12367.
  • 13
    Mustafa AS. Identification of T-cell activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG and Mycobacterium w. Int J Lepr 1988;50: 26573.
  • 14
    Mustafa AS, Shaban FA, Abal AT et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognised by antigen-specific human CD4+ T cell lines. Infect Immun 2000;68: 393340.
  • 15
    Al-Attiyah R, Shaban FA, Wiker HG, Oftung F, Mustafa AS. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 2003;71: 195360.
  • 16
    Mustafa AS, Shaban FA, Al-Attiyah R et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 2003;57: 12534.
  • 17
    Mustafa AS, Amoudy HA, Wiker HG et al. Comparison of antigen specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 1998;48: 53543 .
  • 18
    Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 2002;130: 3742.
  • 19
    Harboe M, Nagai S. MPB70, a unique antigen of Mycobacterium bovis BCG. Am Rev Respir Dis 1984;129: 44452.
  • 20
    Wiker HG, Konstantin P, Lyashchenko A et al. Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis. Infect Immun 1998;66: 144552.
  • 21
    Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284: 15203.
  • 22
    Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997;45: 11531.
  • 23
    Harboe M, Wiker HG. Secreted proteins of Mycobacterium leprae. Scand J Immunol 1998;48: 57784.
  • 24
    Weinrich Olsen A, Van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001;69: 27738.
  • 25
    Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000;30: 172432.
  • 26
    Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19: 93129.
  • 27
    Mustafa AS, Qvigstad E. HLA-DR restricted antigen induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. Int J Lepr 1988;57: 111.
  • 28
    Mustafa AS, Lundin KEA, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the mycobacterial 65-kilodalton heat shock protein (HSP65) recognised by human CD4+ T cells of the Mycobacterium leprae memory repertoire. Infect Immun 1999;67: 56839.
  • 29
    Oftung F, Geluk A, Lundin KEA et al. THM. Mapping of multiple HLA class II restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein. Infect Immun 1994;62: 54118.
  • 30
    Oftung F, Lundin KEA, Geluk A et al. Primary structure and MHC restriction of peptide defined T-cell epitopes from recombinantly expressed mycobacterial protein antigens. Med Principles Pract 1997;6: 6673.
  • 31
    Aizawa M. DRw53. In: Aizawa, M, ed. HLA in Asia-Oceania. Hokkaido University Press, Sapporo, Japan 1986, 175.
  • 32
    Panigada M, Sturniolo T, Besozzi G et al. Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins. Infect Immun 2002;70: 7985.
  • 33
    Vordermeier M, Whelan AO, Hewinson RG. Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Infect Immun 2003;71: 19807.
  • 34
    De Groot AS, Jesdale BM, Szu E, Schafer JR, Chics RM, Deocampo G. An interactive web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses 1997;13: 52931.
  • 35
    Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. Precise prediction of major histocompatibility complex class-II peptide interaction based on peptide side chain scanning. J Exp Med 1994;180: 23538.
  • 36
    Sturniolo T, Bono E, Ding J et al. Generation of tissue-specific and promiscuous HLA ligand data base using DNA microarrays and virtual HLA class II matrices. Nat Biotech 1999;17: 55561.
  • 37
    Hammer J, Sturniolo T, Sinigaglia F. HLA class II peptide binding specificity and autoimmunity. Adv Immunol 1997;66: 67100.
  • 38
    Manici S, Sturniolo T, Imro MA et al. Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leucocyte antigen DR11. J Exp Med 1999;189: 8716.